Clayton et al. [12], [13] showed that exosomes released by breast-, mesotelioma and prostate cancer cell lines expressed NKG2D ligands with ability to down modulate the cognate NK cell receptor and impair the cytotoxic anti-cancer immune response. This evidence concerns the gene KLRD1 and cancer.